Browsing by Author "Stave, Gregg M"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Open Access Guidance to employers on integrating e-cigarettes/electronic nicotine delivery systems into tobacco worksite policy.(J Occup Environ Med, 2015-03) Whitsel, Laurie P; Benowitz, Neal; Bhatnagar, Aruni; Bullen, Chris; Goldstein, Fred; Matthias-Gray, Lena; Grossmeier, Jessica; Harris, John; Isaac, Fikry; Loeppke, Ron; Manley, Marc; Moseley, Karen; Niemiec, Ted; OʼBrien, Vince; Palma-Davis, LaVaughn; Pronk, Nico; Pshock, Jim; Stave, Gregg M; Terry, PaulIn recent years, new products have entered the marketplace that complicate decisions about tobacco control policies and prevention in the workplace. These products, called electronic cigarettes (e-cigarettes) or electronic nicotine delivery systems, most often deliver nicotine as an aerosol for inhalation, without combustion of tobacco. This new mode of nicotine delivery raises several questions about the safety of the product for the user, the effects of secondhand exposure, how the public use of these products should be handled within tobacco-free and smoke-free air policies, and how their use affects tobacco cessation programs, wellness incentives, and other initiatives to prevent and control tobacco use. In this article, we provide a background on e-cigarettes and then outline key policy recommendations for employers on how the use of these new devices should be managed within worksite tobacco prevention programs and control policies.Item Open Access Worksite Temperature Screening for COVID-19.(Journal of occupational and environmental medicine, 2021-04-28) Stave, Gregg M; Smith, Sharon E; Hymel, Pamela A; Heron, Richard JLObjective
To determine whether temperature screening is useful in detecting and reducing workplace transmission of SARS-CoV-2.Methods
A survey was conducted to determine whether temperature screening successfully identified workers with COVID-19 among a convenience sample of medical directors of multinational corporations in a wide range of industries.Results
More than 15 million screenings were performed by 14 companies. Fewer than 700 episodes of fever were identified. Of these, only about 53 cases of COVID-19 were detected. By contrast about 2000 workers with diagnosed COVID-19 were in the workplace and not detected by screening.Conclusions
One case of COVID-19 was identified by screening for approximately every 40 cases that were missed. Worksite temperature screening was ineffective for detecting workers with COVID-19 and is not recommended.